RPRX
Royalty Pharma plc - Ordinary Shares - Class A

7,312
Mkt Cap
$22.31B
Volume
432,862.00
52W High
$41.24
52W Low
$25.40
PE Ratio
22.10
RPRX Fundamentals
Price
$38.47
Prev Close
$38.64
Open
$38.84
50D MA
$38.67
Beta
0.34
Avg. Volume
4.66M
EPS (Annual)
$1.91
P/B
2.58
Rev/Employee
$22.86M
Loading...
Loading...
News
all
press releases
Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the stock in a transaction on Friday, December 26th. The shares were sold at an average price of $39.32...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics
(RTTNews) - Royalty Pharma plc (RPRX) announced that it has acquired the final portion of PTC Therapeutics' remaining royalty interest in Roche's Evrysdi. The transaction includes an upfront payment...
Nasdaq News: Markets·4d ago
News Placeholder
Royalty Pharma (NASDAQ:RPRX) EVP Sells $786,400.00 in Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of Royalty Pharma stock in a transaction dated Friday, December 26th. The shares were sold at an average price...
MarketBeat·4d ago
News Placeholder
Royalty Pharma PLC $RPRX Shares Sold by Marathon Asset Management Ltd
Marathon Asset Management Ltd cut its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 26.5% in the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·4d ago
News Placeholder
World Investment Advisors Takes $1.70 Million Position in Royalty Pharma PLC $RPRX
World Investment Advisors purchased a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·5d ago
News Placeholder
Royalty Pharma PLC $RPRX Stock Holdings Lifted by Voya Investment Management LLC
Voya Investment Management LLC increased its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.0% during the third quarter, according to its most recent Form 13F filing with...
MarketBeat·8d ago
News Placeholder
Swedbank AB Acquires 42,800 Shares of Royalty Pharma PLC $RPRX
Swedbank AB grew its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 0.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·9d ago
News Placeholder
Friedenthal Financial Acquires Shares of 29,322 Royalty Pharma PLC $RPRX
Friedenthal Financial acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·9d ago
News Placeholder
Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 20,000 Shares
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the firm's stock in a transaction dated Friday, December 19th. The stock was sold at an average price of...
MarketBeat·10d ago
News Placeholder
Royalty Pharma (NASDAQ:RPRX) EVP Sells $767,600.00 in Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Marshall Urist sold 20,000 shares of the company's stock in a transaction that occurred on Friday, December 19th. The shares were sold at an...
MarketBeat·11d ago
<
1
2
...
>

Latest RPRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.